Skip to content

Solventum

NYSE: SOLV · USD

Solventum financials

6 charts

Revenue

USD millions

$2,209M
Solventum Revenue. Quarterly values and changes versus the preceding comparable period. Missing values are unavailable.
PeriodRevenue
FY 2024 Q1$2,016M; Change unavailable vs FY 2023 Q4
FY 2024 Q2$2,081M; +3.2% vs FY 2024 Q1
FY 2024 Q3$2,082M; 0.0% vs FY 2024 Q2
FY 2024 Q4$2,075M; −0.3% vs FY 2024 Q3
FY 2025 Q1$2,070M; −0.2% vs FY 2024 Q4
FY 2025 Q2$2,161M; +4.4% vs FY 2025 Q1
FY 2025 Q3$2,096M; −3.0% vs FY 2025 Q2
FY 2025 Q4$1,998M; −4.7% vs FY 2025 Q3
FY 2026 Q1$2,007M; +0.5% vs FY 2025 Q4
FY 2026 Q2$2,209M; +10.1% vs FY 2026 Q1
Mar 31, 2024 through Sep 25, 2026

Free cash flow

USD millions

$144M
Solventum Free cash flow. Quarterly values and changes versus the preceding comparable period. Missing values are unavailable.
PeriodFree cash flow
FY 2024 Q1$340M; Change unavailable vs FY 2023 Q4
FY 2024 Q2$297M; −12.6% vs FY 2024 Q1
FY 2024 Q3$76M; −74.4% vs FY 2024 Q2
FY 2024 Q4$92M; +21.1% vs FY 2024 Q3
FY 2025 Q1$-80M; −187.0% vs FY 2024 Q4
FY 2025 Q2$59M; +173.8% vs FY 2025 Q1
FY 2025 Q3$-21M; −135.6% vs FY 2025 Q2
FY 2025 Q4$32M; +252.4% vs FY 2025 Q3
FY 2026 Q1$-273M; −953.1% vs FY 2025 Q4
FY 2026 Q2$144M; +152.7% vs FY 2026 Q1

Net margin

%

4.16%
Solventum Net margin. Reported fiscal history.
Fiscal period%
FY 2024 Q111.76%
FY 2024 Q24.28%
FY 2024 Q35.86%
FY 2024 Q41.49%
FY 2025 Q16.62%
FY 2025 Q24.16%
FY 2025 Q360.4%
FY 2025 Q43.15%
FY 2026 Q10.65%
FY 2026 Q24.16%

P/E

× · TTM · Daily

10.82×
Solventum P/E. Monthly closing observations; inspect daily values with the chart arrow keys.
Close date× · TTM · DailyFinancials through
2025-03-3127.72×2024-12-31
2025-04-3024.1×2024-12-31
2025-05-3033.71×2025-03-31
2025-06-3034.98×2025-03-31
2025-07-3132.91×2025-03-31
2025-08-2933.7×2025-06-30
2025-09-3033.66×2025-06-30
2025-10-3131.83×2025-06-30
2025-11-289.81×2025-09-30
2025-12-319.12×2025-09-30
2026-01-308.86×2025-09-30
2026-02-278.54×2025-09-30
2026-03-317.38×2025-12-31
2026-04-307.61×2025-12-31
2026-05-299.19×2026-03-31
2026-06-309.46×2026-03-31
2026-07-3110.47×2026-03-31
2026-08-3111×2026-06-30
2026-09-2510.82×2026-06-30

ROIC

% · Annual / TTM

17.18%
Solventum ROIC. Reported fiscal history.
Fiscal period% · Annual / TTM
FY 2024 Q1—
FY 2024 Q2—
FY 2024 Q3—
FY 2024 Q4—
FY 2025 Q1—
FY 2025 Q2—
FY 2025 Q321.06%
FY 2025 Q420.41%
FY 2026 Q117.75%
FY 2026 Q217.18%

Capital allocation

% of tracked cash uses

$371M
Solventum capital allocation. Quarterly values. Missing values are unavailable.
PeriodCapexAcquisitionsBuybacksDividendsDebt repaymentsTracked uses
FY 2024 Q1100% · $102MUnavailableUnavailableUnavailable0% · $0M100% · $102M
FY 2024 Q2100% · $58MUnavailableUnavailableUnavailable0% · $0M100% · $58M
FY 2024 Q331.74% · $93MUnavailableUnavailableUnavailable68.26% · $200M100% · $293M
FY 2024 Q455.95% · $127MUnavailableUnavailableUnavailable44.05% · $100M100% · $227M
FY 2025 Q152.15% · $109MUnavailable0% · $0MUnavailable47.85% · $100M100% · $209M
FY 2025 Q252.38% · $110MUnavailable0% · $0MUnavailable47.62% · $100M100% · $210M
FY 2025 Q33.38% · $97MUnavailableUnavailableUnavailable96.62% · $2,770M100% · $2,867M
FY 2025 Q438.65% · $63MUnavailableUnavailableUnavailable61.35% · $100M100% · $163M
FY 2026 Q155.63% · $84MUnavailable44.37% · $67MUnavailable0% · $0M100% · $151M
FY 2026 Q222.37% · $83MUnavailable77.63% · $288MUnavailable0% · $0M100% · $371M

Sources and calculations

Company filings · USD · Last checked 2026-10-18. Missing inputs remain unavailable. Your chart selection and layout are saved in this browser for Solventum.

All charts share the selected dates. Quarterly/Yearly changes fiscal charts; valuation keeps completed daily closes on a published TTM basis. Later restatements can delay that basis. Historical mean, median and pricing labels use the selected range and do not estimate intrinsic fair value.

SBC deduction is an optional economic-cost scenario for FCF-based metrics. Missing SBC never becomes zero.

Revenue
Reported revenue from company filings.
Free cash flow
Operating cash flow − reported cash capital investment. PPE purchases are preferred; the productive-assets fallback also includes software and intangibles. Reflects the SBC option and can differ from issuer-defined FCF.
Net margin
Reported net income / revenue × 100.
P/E
Completed closing price × diluted shares / TTM earnings attributable to common shareholders.
ROIC
NOPAT / average invested capital × 100. NOPAT = operating income × (1 − effective tax rate). Invested capital = equity including noncontrolling interests + debt − cash and equivalents. Average uses period end and one year earlier.
Capital allocation
Reported cash uses as a percentage of tracked uses. Missing categories remain unavailable; SBC is noncash and excluded.
Reported revenue and sources